Lecrolyn

Sodium cromoglicate, the active ingredient in Lecrolyn, is a mast cell stabilizer presented as an ophthalmic solution for ocular use. It is approved in the European Union for the management of allergic conjunctivitis and ocular itching due to allergy, providing relief for patients who require prescription therapy.

GNH USA supplies Lecrolyn as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics worldwide under strict quality‑assured conditions. The company adheres to EU GMP standards and supports global procurement for eye care specialists.

Sodium cromoglicate (Lecrolyn) is used to manage allergic eye conditions by stabilising mast cells.

Allergic conjunctivitis: reduces ocular redness, swelling and itching associated with allergic reactions. Ocular itching due to allergy: relieves itching and discomfort in the eyes caused by allergens. Seasonal allergic conjunctivitis: controls symptoms during pollen or seasonal allergen exposure.

Adverse reactions are generally mild and transient.

Common Side Effects: - Burning or stinging sensation on instillation. - Temporary blurred vision. - Mild eye irritation or foreign‑body sensation. - Conjunctival hyperemia. - Tearing or increased lacrimation. - Mild headache.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling of the eyelids or face. - Persistent or worsening eye inflammation. - Corneal ulceration or keratitis. - Vision loss or significant visual disturbance. - Secondary ocular infection. - Persistent ocular pain.

Before using Lecrolyn, consider the following safety measures.

Pregnancy: safety not established; use only if clearly needed. Breastfeeding: unknown; weigh potential benefits against risks. Contact lens wearers: remove lenses before instillation and wait at least 15 minutes before reinserting. Concomitant ocular medications: administer other drops at least five minutes apart to avoid dilution. Allergy to sodium cromoglicate: contraindicated. Store at room temperature: keep in the original container, protect from light and moisture.

Lecrolyn may interact with other ophthalmic agents; monitor patients accordingly.

Major Interactions (Avoid): - Concurrent use with ophthalmic anesthetics may increase corneal toxicity. - Systemic mast cell stabilisers may produce additive effects and are not recommended. - Topical corticosteroids can mask signs of infection when used together.

Moderate Interactions (Monitor Closely): - Antihistamine eye drops may reduce the efficacy of sodium cromoglicate. - Non‑steroidal anti‑inflammatory eye drops can increase ocular irritation when combined. - Preservative‑containing solutions may exacerbate local sensitivity.